Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Interferon alpha 2b in the treatment of uveitic cystoid macular edema.

Butler NJ, Suhler EB, Rosenbaum JT.

Ocul Immunol Inflamm. 2012 Apr;20(2):86-90. doi: 10.3109/09273948.2011.645989.

PMID:
22409560
2.

[Effectiveness of interferon alpha in the treatment of uveitis macular edema refractory to corticosteroid and/or immunosuppressive treatment].

Paire V, Lebreton O, Weber M.

J Fr Ophtalmol. 2010 Mar;33(3):152-62. doi: 10.1016/j.jfo.2010.01.008. Epub 2010 Feb 24. French.

3.

Interferon alfa-2a: a new treatment option for long lasting refractory cystoid macular edema in uveitis? A pilot study.

Deuter CM, Koetter I, Guenaydin I, Stuebiger N, Zierhut M.

Retina. 2006 Sep;26(7):786-91.

PMID:
16963852
4.

Intravitreal triamcinolone acetonide as adjunctive treatment with systemic therapy for uveitic macular edema.

Habot-Wilner Z, Sallam A, Pacheco PA, Do HH, McCluskey P, Lightman S.

Eur J Ophthalmol. 2011;21 Suppl 6:S56-61. doi: 10.5301/EJO.2010.6062.

PMID:
23264330
5.

EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA.

Khurana RN, Porco TC.

Retina. 2015 Aug;35(8):1640-6. doi: 10.1097/IAE.0000000000000515.

PMID:
25741813
6.

Tomographic assessment of therapeutic response to uveitic macular oedema.

Sivaprasad S, Ikeji F, Xing W, Lightman S.

Clin Exp Ophthalmol. 2007 Nov;35(8):719-23.

PMID:
17997774
7.

Anti-TNF-α agents for refractory cystoid macular edema associated with noninfectious uveitis.

Schaap-Fogler M, Amer R, Friling R, Priel E, Kramer M.

Graefes Arch Clin Exp Ophthalmol. 2014 Apr;252(4):633-40. doi: 10.1007/s00417-013-2552-8. Epub 2013 Dec 24.

PMID:
24366669
8.

Effect of interferon α2a in cystoid macular edema due to intraocular infection.

Qian Z, Fardeau C, Cardoso JN, Jellab B, Fan X, LeHoang P.

Eur J Ophthalmol. 2015 Sep-Oct;25(5):431-6. doi: 10.5301/ejo.5000591. Epub 2015 Mar 16.

PMID:
25790810
9.

Tocilizumab treatment for refractory uveitis-related cystoid macular edema.

Adán A, Mesquida M, Llorenç V, Espinosa G, Molins B, Hernández MV, Pelegrín L.

Graefes Arch Clin Exp Ophthalmol. 2013 Nov;251(11):2627-32. doi: 10.1007/s00417-013-2436-y. Epub 2013 Jul 27.

PMID:
23893042
10.

Intravitreal bevacizumab in refractory uveitic macular edema: one-year follow-up.

Cervantes-Castañeda RA, Giuliari GP, Gallagher MJ, Yilmaz T, MacDonell RE, Quinones K, Foster CS.

Eur J Ophthalmol. 2009 Jul-Aug;19(4):622-9.

PMID:
19551679
11.

Long-term effect of acetazolamide treatment of patients with uveitic chronic cystoid macular edema is limited by persisting inflammation.

Schilling H, Heiligenhaus A, Laube T, Bornfeld N, Jurklies B.

Retina. 2005 Feb-Mar;25(2):182-8.

PMID:
15689809
12.

Short-term results of a single intravitreal bevacizumab (avastin) injection versus a single intravitreal triamcinolone acetonide (kenacort) injection for the management of refractory noninfectious uveitic cystoid macular edema.

Lasave AF, Zeballos DG, El-Haig WM, Díaz-Llopis M, Salom D, Arevalo JF.

Ocul Immunol Inflamm. 2009 Nov-Dec;17(6):423-30. doi: 10.3109/09273940903221610.

PMID:
20001264
13.

Influence of the vitreomacular interface on the efficacy of intravitreal therapy for uveitis-associated cystoid macular oedema.

Munk MR, Ram R, Rademaker A, Liu D, Setlur V, Chau F, Schmidt-Erfurth U, Goldstein DA.

Acta Ophthalmol. 2015 Nov;93(7):e561-7. doi: 10.1111/aos.12699. Epub 2015 Feb 23.

14.

Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis.

Deuter CM, Kötter I, Günaydin I, Stübiger N, Doycheva DG, Zierhut M.

Br J Ophthalmol. 2009 Jul;93(7):906-13. doi: 10.1136/bjo.2008.153874. Epub 2009 Mar 24.

PMID:
19321469
15.
16.

Intravitreal adalimumab for refractory uveitis-related macular edema.

Androudi S, Tsironi E, Kalogeropoulos C, Theodoridou A, Brazitikos P.

Ophthalmology. 2010 Aug;117(8):1612-6. doi: 10.1016/j.ophtha.2009.12.011. Epub 2010 Apr 8.

PMID:
20378179
17.

Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema.

Androudi S, Letko E, Meniconi M, Papadaki T, Ahmed M, Foster CS.

Ocul Immunol Inflamm. 2005 Apr-Jun;13(2-3):205-12.

PMID:
16019680
18.

Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.

Taylor SR, Habot-Wilner Z, Pacheco P, Lightman SL.

Ophthalmology. 2009 Apr;116(4):797-801. doi: 10.1016/j.ophtha.2008.10.033.

PMID:
19344827
19.

Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study.

Mackensen F, Heinz C, Becker MD, Heiligenhaus A.

Retina. 2008 Jan;28(1):41-5. doi: 10.1097/IAE.0b013e318156db75.

PMID:
18185136
20.

Intravitreal bevacizumab versus triamcinolone acetonide for refractory uveitic cystoid macular edema: a randomized pilot study.

Soheilian M, Rabbanikhah Z, Ramezani A, Kiavash V, Yaseri M, Peyman GA.

J Ocul Pharmacol Ther. 2010 Apr;26(2):199-206. doi: 10.1089/jop.2009.0093.

PMID:
20307215

Supplemental Content

Support Center